LAINEY ORTIZ: Open Payments
NPI 1801352513 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,281 in 124 payments from 21 companies in 2025. Trend: 2023 $562 · 2024 $1,802 · 2025 $2,281
Food & beverage: $2,096Education: $185
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 14 | $304 |
| ABBVIE INC. | 20 | $293 |
| Janssen Biotech, Inc. | 11 | $258 |
| PFIZER INC. | 6 | $204 |
| UCB, Inc. | 12 | $169 |
| Lilly USA, LLC | 6 | $123 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 5 | $95 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $83 |
| Regeneron Healthcare Solutions, Inc. | 5 | $80 |
Products named: Opzelura, DUPIXENT, TREMFYA, SKYRIZI, CIBINQO, Bimzelx, EBGLYSS, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
